NCT05131958

Brief Summary

"Nasal polyposis is a chronic inflammation of the sinonasal mucosa which is characterized by the development of polyps in the sinonasal cavities. In the general population, its prevalence is 4% with a clear increase from the age of 50 years. When drug treatment is not effective, and the patient's quality of life is impaired, surgery is proposed. It allows to widen the nasal cavities with aerodynamic and acoustics effects on speech. There are few studies, that have focused on the impact of NP and its treatment on speech. Yet there is a real demand from patients to obtain answers related to the impact of this surgery on their voice. Preoperatively and postoperatively, the resonance will be disturbed: polyps will impacted the quality of the nasal sounds. And after surgery, the new anatomical shape can create an excessive resonance in the nasal cavities. Indeed, there is a diversity of acoustic effects that differ according to the sinuses involved, the nature and type of surgery and the anatomical and physiological specificities of the patient. The impairment of acoustic properties after surgery is diverse and little known. The surgery improves the communication between sinuses and nasal cavities but the real impact on nasal resonance still unknown. The particularity of this pathology stands in the obstruction of the sinonasal cavity by polyps. On this study, it represents a model of nasality disturbance/impairment ? Indeed, all aspects of nasality will be altered : the articulation by the obstruction of the sino-nasal cavities, the aerodynamic by a disturbance of the circulation of the airflow within the nasal cavity, acoustics by an alteration of the resonance of this flow, and finally the perception of speech by others where the comprehension of speech is difficult. Thus, the investigators wish to observe this dysfunction in a multipara metric way in order to have an accurate approach. This population is therefore ideal. In preoperative, it will allow to measure by aerodynamic, articulatory, acoustic, and perceptive data taking this dysfunction, to give precise answers. Then, postoperatively, these measurements will be repeated to observe a return to the expected functioning of the nasal cavity. Indeed, the cavities being no longer congested, a greater flow of nasal air would be expected, which would have acoustic consequences on the resonance of nasal sounds. This could be accentuated because of the new anatomical configuration due to the surgery. Perceptually, the voice after surgery should no longer be considered as pathological. In addition to the linguistics aspect, this population has the particularity of having a strongly impacted quality of life. The investigators would therefore like to measure this impact on quality of life before and after surgery. For this study, the main objective is to measure the articulatory, aerodynamics, acoustics and perceptive impact of the nasal polyposis on speech before and after surgery. the secondaries objectives are to:

  • Compare the differences in aerodynamic, acoustic, articulatory and perceptual changes between the ""presence of polyps in the nasal and sinus cavities"" group and the ""presence of polyps in the sinus cavities"" group
  • Compare the modifications on the speech of the pathology before and after surgical treatment
  • Identify the elements related to the quality of life impacted by this pathology.
  • Identify the glottic compensation strategies induced by the pathology
  • Compare preoperative and postoperative nasal resonance and the relationship between nasal and sinus cavities using 3D models
  • Validate the adequacy of the nasality-speech questionnaire for patients with sinonasal polyposis"

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 23, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 23, 2021

Status Verified

July 1, 2021

Enrollment Period

9 months

First QC Date

July 31, 2021

Last Update Submit

November 22, 2021

Conditions

Keywords

Nasal polyposis

Outcome Measures

Primary Outcomes (5)

  • Aerodynamic

    For the aerodynamic measure : with a fibermask, we will record the nasal and oral airflow in liter/second

    Change before surgery and 3 months after surgery

  • Acoustic measure

    For the acoustic measure with a microphone, we will record data in Hertz.

    Change before surgery and 3 months after surgery

  • Perception measure

    To complete questionnaires : VHI

    Change before surgery and 3 months after surgery

  • Perception measure

    To complete questionnaires : SHI

    Change before sugery and 3 months after surgery

  • Perception measure

    To complete questionnaires : The nasal-speech relationship

    Change before surgery and 3 months after surgery

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients suffering from primitive nasal polyposis and who had a surgery for the first time.

You may qualify if:

  • Between 18 and 75 years of age
  • Primitive nasal polyposis and surgery for the first time
  • Not opposing to the study
  • Affiliated to a social security systeme

You may not qualify if:

  • Already had a surgery from the nasal and sinuses cavities
  • Dysphonia or a vocal fold pathology
  • One-sided or secondary nasal polyposis
  • People who aren't able to give his non-opposition
  • Contraindication to the airways endoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AP-HP, Bicêtre Hospital

Le Kremlin-Bicêtre, 94270, France

Location

MeSH Terms

Conditions

Nasal Polyps

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Jean-François PAPON, PhD

    AP-HP, Bicêtre Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean-François PAPON, PhD

CONTACT

Lise Crevier Buchman, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2021

First Posted

November 23, 2021

Study Start

December 1, 2021

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

November 23, 2021

Record last verified: 2021-07

Locations